Select Bibliography

Filter by any of these (after searching):

Qin, Rui

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 29 items

A randomized phase II trial evaluating two non-pharmacologic interventions in cancer survivors for the treatment of sleep-wake disturbances: NCCTG N07C4 (Alliance)

Barton, Debra L , Atherton, Pamela J , Satele, Daniel V , Qin, Rui ... - - Support Care Cancer - 2020

Manuscript - Primary - Primary - Symptom Inter - NCCTG-N07C4

Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy

Beutler, Andreas S. , Kulkarni, Amit A. , Kanwar, Rahul ... - - Ann. Neurol. - 2014

Manuscript - Secondary-not-in-original - Meta-Analysis - Symptom Inter - N08C1 , N08CA

Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance)

Boora, Ganesh K. , Kulkarni, Amit A. , Kanwar, Rahul ... - - J. Neurol. Sci. - 2015

Manuscript - Secondary-not-in-original - Primary - Symptom Inter - N08CA

Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases

Himelstein, Andrew L. , Foster, Jared C. , Khatcheressian, James L. ... - - JAMA - 2017

Manuscript - Primary - Primary - Symptom Inter - CALGB-79804 , CALGB-70604 , CALGB-150804

CALGB 70604 (Alliance): A randomized phase III study of standard dosing vs. longer interval dosing of zoledronic acid in metastatic cancer

Himelstein, Andrew L. , Qin, Rui , Novotny, Paul J. ... - ASCO - J. Clin. Oncol. - 2015

Abstract - Primary - Primary - Symptom Inter - CALGB-70604

A Pilot Study of Long-Acting Octreotide for Symptomatic Malignant Ascites (N04C2)

Jatoi, Aminah , Nieva, Jorge J. , Qin, Rui , Loprinzi, Charles L. ... - - Oncology - 2012

Manuscript - Primary - Primary - Symptom Inter - N04C2

Patient-Reported (EORTC QLQ-CIPN20) Versus Physician-Reported (CTCAE) Quantification of Oxaliplatin- and Paclitaxel/Carboplatin-Induced Peripheral Neuropathy in NCCTG/Alliance Clinical Trials

Le-Rademacher, Jennifer , Kanwar, Rahul , Seisler, Drew ... - - Support Care Cancer - 2017

Manuscript - Secondary-not-in-original - Meta-Analysis - Symptom Inter - N08CA , N08CB

NCCTG N08CA (Alliance): The use of Glutathione for Prevention of Paclitaxel/Carboplatin Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo-Controlled Study

Leal, Alexis D. , Qin, Rui , Atherton, Pamela J. , Haluska, Paul ... - - Cancer - 2014

Manuscript - Primary - Primary - Symptom Inter - N08CA

Doxepin Rinse Versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy With or Without Chemotherapy: A Phase III, Randomized, Double-Blind Trial (NCCTG-N09C6 [Alliance])

Leenstra, James L. , Miller, Robert C. , Qin, Rui ... - - J. Clin. Oncol - 2014

Manuscript - Primary - Primary - Symptom Inter - N09C6

Comparing and Validating Simple Measures of Patient-Reported Peripheral Neuropathy for Oncology Clinical Trials: NCCTG N0897 (Alliance) A Pooled Analysis of 2440 Patients

Liu, Heshan , Tan, Angelina D. , Qin, Rui , Sargent, Daniel J. ... - - SOJ Anesthesiol Pain Manag - 2015

Manuscript - Primary - Primary - Health Outcome - N0897

Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of Pregabalin for Alleviating Hot Flashes, N07C1

Loprinzi, Charles L. , Qin, Rui , Baclueva, Ernie P. ... - - J Clin Oncol - 2010

Manuscript - Primary - Primary - Symptom Inter - N07C1

Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)

Loprinzi, Charles L. , Qin, Rui , Dakhil, Shaker R. ... - - J. Clin. Oncol - 2014

Manuscript - Primary - Primary - Symptom Inter - N08CB

N09C6 (Alliance) - A Phase III, Randomized Double-Blind Study of Doxepin Rinse versus Placebo in the Treatment of Acute Oral Mucositis Pain: Secondary analysis of the continuation phase

Miller, Robert C. , Leenstra, James L. , Qin, Rui ... - - European Journal of Cancer - 2013

Abstract - Primary - Primary - Symptom Inter - N09C6

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting

Navari, Rudolph M. , Qin, Rui , Ruddy, Kathryn J. , Liu, Heshan ... - - N. Engl. J. Med. - 2016

Manuscript - Primary - Primary - Symptom Inter - A221301

Olanzapine For The Prevention Of Chemotherapy Induced Nausea And Vomiting (CINV) In Patients Receiving Highly Emetogenic Chemotherapy (HEC): Alliance A221301 A Randomized, Double-Blind, Placebo-Controlled Trial

Navari, Rudolph M. , Qin, Rui , Ruddy, Kathryn J. , Liu, Heshan ... - ASCO Pal - J. Clin. Oncol. - 2015

Abstract - Primary - Primary - Symptom Inter - A221301

Clinical course of patients with oxaliplatin-associated neuropathy: N08CB (Alliance)

Pachman, Deirdre R. , Qin, Rui , Seisler, Drew K. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Secondary - Primary - Symptom Inter - N08CB

Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)

Pachman, Deirdre R. , Qin, Rui , Seisler, Drew K. , Smith, Ellen M.L. ... - - J. Clin. Oncol - 2015

Manuscript - Secondary - Primary - Symptom Inter - N08CB

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505)

Pachman, Deirdre R. , Qin, Rui , Seisler, Drew ... - - Support Care Cancer - 2016

Manuscript - Primary - Primary - Symptom Inter - A151505 , N08C1 , N08CB

NCCTG N10C2 (Alliance) – A Double-Blind, Placebo-Controlled Study of Magnesium Supplements to Reduce Menopausal Hot Flashes

Park, Haeseong , Qin, Rui , Smith, Thomas J. , Atherton, Pamela J. ... - - Menopause - 2015

Manuscript - Primary - Primary - Symptom Inter - N10C2

NCCTG N10C2 (Alliance): A double-blind, placebo-controlled study of magnesium supplements to reduce menopausal hot flashes

Park, Haeseong , Qin, Rui , Smith, Thomas J. , Atherton, Pamela J. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - Symptom Inter - N10C2

A Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Flaxseed for the Treatment of Hot Flashes1:NCCTG N08C7

Pruthi, Sandhya , Qin, Rui , Terstreip, Shelby A. , Liu, Heshan ... - - Menopause - 2012

Manuscript - Primary - Primary - Symptom Inter - N08C7

Quality of Life Analysis of N0877 (Alliance): Phase II Trial of Either Dasatinib or Placebo Combined with Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma Multiforme (GBM)

Qin, Rui , Tan, Angelina D. , Sloan, Jeff A. , Johnson, Derek Richard ... - ASCO - J. Clin. Oncol. - 2015

Abstract - Secondary - Primary - Health Outcome - N0877

A Comparison of the Natural History of Oxaliplatin- and Paclitaxel-Induced Neuropathy (NCCTG N08C1, N08CB/Alliance)

Ruddy, Kathryn Jean , Pachman, Dierdre , Qin, Rui , Seisler, Drew K. ... - ASCO - J. Clin. Oncol. - 2015

Abstract - Primary - Primary - Symptom Inter - A151505 , N08C1 , N08CB

Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain

Sio, Terence T. , Le-Rademacher, Jennifer G. , Leenstra, James L. ... - - JAMA - 2019

Manuscript - Primary - Primary - Symptom Inter - A221304

Placebo-Controlled Trial to Determine the Effectiveness of a Urea/Lactic Acid–Based Topical Keratolytic Agent for Prevention of Capecitabine-Induced Hand-Foot Syndrome: North Central Cancer Treatment Group Study N05C5

Wolf, Sherry L. , Qin, Rui , Menon, Smitha P. , Rowland, Kendrith M. ... - - J Clin Oncol - 2010

Manuscript - Primary - Primary - Symptom Inter - N05C5

Change in mammographic density with metformin use: A companion study to NCIC study MA.32.

Wood, Marie E. , Qin, Rui , Le-Petross, Huong T. , Hwang, E Shelley ... - ASCO - J. Clin. Oncol. - 2013

Abstract - No-Endpoint - Trial-Description-Only - Breast - A211201

Venlafaxine to prevent oxaliplatin-induced neuropathy?: A pilot randomized placebo-controlled trial.

Zimmerman, Collin Thomas , Atherton, Pamela J. , Pachman, Deirdre R. ... - ASCO - J. Clin. Oncol. - 2015

Abstract - Primary - Primary - Symptom Inter - NCT01611155

Venlafaxine to Prevent Oxaliplatin-Induced Neuropathy? A Pilot Randomized Placebo Controlled Trial

Zimmerman, Collin , Atherton, Pam , Pachman, Deirdre , Seisler, Drew ... - MASCC / ISOO - Support Care Cancer - 2015

Abstract - Primary - Primary - Symptom Inter - NCT01611155

MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy

Zimmerman, Collin , Atherton, Pamela J. , Pachman, Deirdre ... - - Support Care Cancer - 2016

Manuscript - Primary - Primary - Symptom Inter - NCT01611155